Novartis and Drugs for Neglected Diseases initiative (DNDi) to collaborate on the development of a new oral drug to treat Visceral Leishmaniasis - Africanews English

Novartis and Drugs for Neglected Diseases initiative (DNDi) to collaborate on the development of a new oral drug to treat Visceral Leishmaniasis  Africanews English

Comments

Popular posts from this blog

CDC says skin-disfiguring parasite may be endemic in Texas, present in other states - NBC News